146 related articles for article (PubMed ID: 2941630)
1. Study of the in vivo and in vitro photosensitizing capabilities of uroporphyrin I compared to photofrin II.
Nelson JS; Sun CH; Berns MW
Lasers Surg Med; 1986; 6(2):131-6. PubMed ID: 2941630
[TBL] [Abstract][Full Text] [Related]
2. Comparison of fluorescence and photodynamic activities of whole hematoporphyrin derivative and its enriched active components.
Nelson JS; Wright WH; Berns MW
J Natl Cancer Inst; 1985 Dec; 75(6):1135-40. PubMed ID: 2933546
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of 28 porphyrins and their abilities to localize in mammary mouse carcinoma: uroporphyrin I superior to hematoporphyrin derivative.
El-Far M; Pimstone N
Prog Clin Biol Res; 1984; 170():661-72. PubMed ID: 6241706
[TBL] [Abstract][Full Text] [Related]
4. Use of multiple photosensitizers and wavelengths during photodynamic therapy: a new approach to enhance tumor eradication.
Nelson JS; Liaw LH; Lahlum RA; Cooper PL; Berns MW
J Natl Cancer Inst; 1990 May; 82(10):868-73. PubMed ID: 2139704
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo photosensitizing capabilities of 5-ALA versus photofrin in vascular endothelial cells.
Chang CJ; Sun CH; Liaw LH; Berns MW; Nelson JS
Lasers Surg Med; 1999; 24(3):178-86. PubMed ID: 10229148
[TBL] [Abstract][Full Text] [Related]
6. Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.
Gossner L; Wittke H; Warzecha A; Sroka R; Ernst H; Meier M; Ell C
Br J Cancer; 1991 Jul; 64(1):84-6. PubMed ID: 1830212
[No Abstract] [Full Text] [Related]
7. Photodynamic therapy of C3H mouse mammary carcinoma with haematoporphyrin di-ethers as sensitizers.
Evensen JF; Sommer S; Rimington C; Moan J
Br J Cancer; 1987 May; 55(5):483-6. PubMed ID: 2955805
[TBL] [Abstract][Full Text] [Related]
8. Correlation between photodynamic efficacy of differing porphyrins and membrane partitioning behavior.
Okunaka T; Eckhauser ML; Kato H; Bomaminio A; Yamamoto H; Aizawa K; Sarasua MM; Koehler KA
Lasers Surg Med; 1992; 12(1):98-103. PubMed ID: 1535406
[TBL] [Abstract][Full Text] [Related]
9. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model.
Henderson BW; Fingar VH
Photochem Photobiol; 1989 Mar; 49(3):299-304. PubMed ID: 2525260
[TBL] [Abstract][Full Text] [Related]
10. Experimental evidence on possibility to radiosensitize aggressive tumors by porphyrins.
Luksiene Z
Medicina (Kaunas); 2004; 40(9):868-74. PubMed ID: 15456974
[TBL] [Abstract][Full Text] [Related]
11. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
12. Effects of photodynamic therapy on adhesion molecules and metastasis.
Rousset N; Vonarx V; Eléouet S; Carré J; Kerninon E; Lajat Y; Patrice T
J Photochem Photobiol B; 1999; 52(1-3):65-73. PubMed ID: 10643074
[TBL] [Abstract][Full Text] [Related]
13. Increased efficacy of photodynamic therapy of R3230AC mammary adenocarcinoma by intratumoral injection of Photofrin II.
Gibson SL; van der Meid KR; Murant RS; Hilf R
Br J Cancer; 1990 Apr; 61(4):553-7. PubMed ID: 2139578
[TBL] [Abstract][Full Text] [Related]
14. Enhanced tumor control following sequential treatments of photodynamic therapy (PDT) and localized microwave hyperthermia in vivo.
Waldow SM; Henderson BW; Dougherty TJ
Lasers Surg Med; 1984; 4(1):79-85. PubMed ID: 6235420
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hematoporphyrin photoradiation therapy to treat choroidal melanomas.
Bruce RA
Lasers Surg Med; 1984; 4(1):59-64. PubMed ID: 6235417
[TBL] [Abstract][Full Text] [Related]
16. Picosecond fluorescence of R3230AC mammary carcinoma mitochondria after treatment with hematoporphyrin derivative and Photofrin II in vivo.
Hanzlik CA; Knox RS; Gibson SL; Hilf R
Photochem Photobiol; 1989 Jul; 50(1):45-53. PubMed ID: 2527374
[TBL] [Abstract][Full Text] [Related]
17. Quantum yields and kinetics of the photobleaching of hematoporphyrin, Photofrin II, tetra(4-sulfonatophenyl)-porphine and uroporphyrin.
Spikes JD
Photochem Photobiol; 1992 Jun; 55(6):797-808. PubMed ID: 1409888
[TBL] [Abstract][Full Text] [Related]
18. Photosensitizing effects of hematoporphyrin derivative and photofrin II on the plasma membrane enzymes 5'-nucleotidase, Na+K+-ATPase, and Mg2+-ATPase in R3230AC mammary adenocarcinomas.
Gibson SL; Murant RS; Hilf R
Cancer Res; 1988 Jun; 48(12):3360-6. PubMed ID: 2836053
[TBL] [Abstract][Full Text] [Related]
19. Changes in tumor interstitial pressure induced by photodynamic therapy.
Fingar VH; Wieman TJ; Doak KW
Photochem Photobiol; 1991 Jun; 53(6):763-8. PubMed ID: 1832229
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitization of tumours by porphyrins.
Luksiene Z; Juzenas P; Moan J
Cancer Lett; 2006 Apr; 235(1):40-7. PubMed ID: 15946797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
